Physician profile
Elizabeth E King
NPI 1629161500
$16,784.77
in general payments reported to CMS, 2019-2025
57 companies · $2,843 in 2025
The $2,843 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,098 · 2020: $1,987 · 2021: $1,438 · 2022: $1,604 · 2023: $1,198 · 2024: $1,617 · 2025: $2,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,658.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $4,104.00 | 2019-2025 | Korlym |
| Tandem Diabetes Care, INC. | $1,608.26 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $1,249.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,018.06 | 2019-2023 | Farxiga |
| Medtronic, INC. | $880.81 | 2021-2025 | Minimed 780g, Symplicity G3, Apollotm |
| Amgen INC. | $783.78 | 2019-2025 | Evenity, Prolia, Tepezza |
| Mannkind Corporation | $705.98 | 2019-2025 | Afrezza |
| Abbott Laboratories | $607.89 | 2019-2025 | Freestyle Libre 3 |
| Radius Health, INC. | $493.90 | 2019-2024 | Tymlos |
| Lilly USA, LLC | $400.22 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Insulet Corporation | $389.61 | 2019-2025 | Omnipod |
| Neurocrine Biosciences, INC. | $365.14 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $355.06 | 2020-2025 | |
| Xeris Pharmaceuticals, INC. | $274.71 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Abbvie INC. | $256.46 | 2019-2025 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.